BNP in the differential diagnosis of amiodarone-induced pulmonary toxicity: A case report and review of the literature

Archives of Medical Science

Volumn 2, Issue 2, 2006, Pages 131-133

  Grabowski, Marcin ^a   Małek, Łukasz A ^a   Karpiński, Grzegorz ^a   Filipiak, Krzysztof J ^a   Opolski, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Adverse reactions; Amiodarone; Differential diagnosis; Natriuretic peptide

Indexed keywords

AMIODARONE; BRAIN NATRIURETIC PEPTIDE; PREDNISOLONE;

ACUTE DISEASE; AGED; ANAMNESIS; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; HEART EJECTION FRACTION; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LUNG FIBROSIS; LUNG TOXICITY; MALE; MEDICAL LITERATURE; PLETHYSMOGRAPHY; PROTEIN ANALYSIS; PULMONARY HYPERTENSION; REVIEW; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY;

EID: 33745790454     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106: 416-22.
2. Januzzi JL Jr, Camargo CA, Anwaruddin S, Baggish AL, Chen AA, Krauser DG, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study. Am J Cardiol 2005; 95: 948-54.
3. Shiga T, Hosaka F, Wakaumi M, Matsuda N, Tanizaki K, Kajimoto K, et al. Amiodarone decreases plasma brain natriuretic peptide level in patients with heart failure and ventricular tachyarrhythmia. Cardiovasc Drugs Ther 2003; 17: 325-33.
4. Takemura K, Yasumura Y, Hirooka K, Hanatani A, Nakatani S, Komamura K, et al. Low-dose amiodarone for patients with advanced heart failure who are intolerant of beta-blockers. Circ J 2002; 66: 441-4.
5. Martin WJ, Rosenow EC. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest 1988; 93: 1067-75.
6. Van Mieghem W, Coolen L, Malysse I, Lacquet LM, Deneffe GJ, Demedts MG. Amiodarone and the development of ARDS after lung surgery. Chest 1994; 105: 1642-5.
7. Ashrafian H, Davey R Is amiodarone an underrecognized cause of acute respiratory failure in the ICU? Chest 2001; 120: 275-82.
8. Singh SN, Fisher SG, Deedwania PC, Rohatgi P, Singh BN, Fletcher RD. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). J Am Coll Cardiol 1997; 30: 514-7.
9. Ott MC, Khoor A, Leventhal JP, Paterick TE, Burger CD. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 2003; 123: 646-51.
10. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al.; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-37